Information for new investors. “Ginkgo is partnering with Cronos Group to produce cultured cannabinoids. With Cronos’ recent announcement of the production of a new 84,000 square foot GMP compliant fermentation and manufacturing facility in Canada, they hope to produce high-quality cultured cannabinoids at commercial scale.” https://www.genengnews.com/insights/ginkgo-bioworks-co-founder-honored-with-rosalind-franklin-award/